Elevated levels of Prostaglandin E2 (PGE2), an eicosanoid synthesized from arachidonic acid by the inducible cyclooxygenase-2 (COX-2), exert strong immunosuppressive effect in the tumor microenvironment. Also, upregulation of COX-2 was shown in several types of tumors. Counteracting this immunosuppress...
Poster Presentation Dates All odd-numbered posters will be presented on Thursday, Nov. 10, 2022, while even-numbered posters will be presented on Friday, Nov. 11, 2022. On Thursday, Nov. 10 posters will be on display from 9 a.m.–9 p.m. EST, with the presenting authors required to ...
Poster to provide details on study design and expansion phase for ongoing Phase 1 study in patients with advanced solid malignancies SOUTH SAN FRANCISCO, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading human genetics ...
Poster viewing session and reception Please note, the recorded sessions post-meeting are NOT included in your registration fee. If you would like view the recorded sessions after the meeting concludes please view the Add-on Options for the cost to add the Head and Neck onDemand to your registr...
Cytovia Therapeutics, Inc. announced new preclinical data for its TALEN® gene-edited, iPSC-derived NK cells and GPC3-targeted Flex-NK™ bispecific antibodies.
Poster hall:11 November 2022, 9:00am - 9:00pm EST Abstracts will be available on SITC’s website located at www.sitcancer.org at 8am EST on Nov. 7, 2022 Contact Information: Glycotope GmbH Dr. Patrik Kehler (CSO)...
Ivonescimab is a novel, potential first-in-class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. The poster describes how ivonescimab displays unique cooperative bi...
To learn more about CD137 Bicycle TICA® mechanism of action, see Poster #1356 at this conference. Bicycle Therapeutics, Inc. 4 Hartwell Place Lexington, MA 02421-3122, USA T. +1 617-945-8155 BicycleTx Limited Portway Building Granta Park Cambridge CB21 6GS, UK T. +44 (0)1223 ...
The abstract and the poster will be available on Medivir’s website after the presentation. For additional information, please contact Magnus Christensen, CFO Telephone: +46 8 5468 3100 E-mail:magnus.christensen@medivir.com About fost...
Data supporting Catamaran’s lead program, CAT-248, will be presented in a poster titled “Engineering CD70-directed CAR-NK cells for the Treatment of Hematological and Solid Malignancies.” Highlights include: The non-viral TcBuster™...